Cita APA (7a ed.)
Esposti, L. D., Perrone, V., Veronesi, C., Buda, S., Rossini, R., & Degli Esposti, L. (2018). All-cause mortality, cardiovascular events, and health care costs after 12 months of dual platelet aggregation inhibition after acute myocardial infarction in real-world patients: Findings from the Platelet-aggregation Inhibition: Persistence with treatment and cardiovascular Events in Real world (PIPER) study. Vascular Health & Risk Management, 14, 383-393.
Cita Chicago Style (17a ed.)
Esposti, Luca Degli, Valentina Perrone, Chiara Veronesi, Stefano Buda, Roberta Rossini, y Luca Degli Esposti. "All-cause Mortality, Cardiovascular Events, and Health Care Costs After 12 Months of Dual Platelet Aggregation Inhibition After Acute Myocardial Infarction in Real-world Patients: Findings from the Platelet-aggregation Inhibition: Persistence with Treatment and Cardiovascular Events in Real World (PIPER) Study." Vascular Health & Risk Management 14 (2018): 383-393.
Cita MLA (9a ed.)
Esposti, Luca Degli, et al. "All-cause Mortality, Cardiovascular Events, and Health Care Costs After 12 Months of Dual Platelet Aggregation Inhibition After Acute Myocardial Infarction in Real-world Patients: Findings from the Platelet-aggregation Inhibition: Persistence with Treatment and Cardiovascular Events in Real World (PIPER) Study." Vascular Health & Risk Management, vol. 14, 2018, pp. 383-393.
Precaución: Estas citas no son 100% exactas.